Becton Dickinsonvs.Stryker
BDX vs SYK · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices — from surgery and cardiology to robotics.
Stryker is about 3.0× larger than Becton Dickinson by market cap; year to date, Becton Dickinson leads (−0.4% vs −6.2%).
Side by side
| BDX | SYK | |
|---|---|---|
| Market cap | $41.9B | $127B |
| Price | $151.94 | $329.78 |
| Today | +0.7% | +0.8% |
| Return YTD | −0.4% | −6.2% |
| Return 1Y | +8.9% | −16.5% |
| P/E | 36.8 | 38.0 |
| P/S | 2.0 | 5.0 |
| P/B | 1.7 | 5.5 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
Becton DickinsonBDX
American medtech group with a broad portfolio of medical consumables, diagnostics and drug delivery (syringes, needles).
Full BDX profile →StrykerSYK
American medtech company focused on orthopaedics, surgical equipment and robot-assisted surgery (Mako).
Full SYK profile →More comparisons in Medtech & devices
See where BDX and SYK sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →